We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

WHEATON® Announces Acquisition of CELLine™

News   Jul 10, 2012

 
WHEATON® Announces Acquisition of CELLine™
 
 
 

RELATED ARTICLES

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Potential Therapeutic Target for Alzheimer's

News

A previously unknown gene and associated protein which could potentially be suppressed to slow the advance of Alzheimer’s have been discovered, presenting a potential therapeutic target to combat the disease.

READ MORE

Cell Biology: All in a Flash!

News

Researchers have developed a method for eliminating essential proteins from cells with a flash of light, making it possible to study the function of essential proteins.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE